Article
PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a…
OncoTargets and Therapy · 2014 · Liu YR, Jiang YZ, Zuo WJ, Yu KD, Shao ZM
Key facts
| Title | PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysis |
|---|---|
| First author | Liu YR, Jiang YZ, Zuo WJ, Yu KD, Shao ZM |
| Journal | OncoTargets and Therapy |
| Published | Apr 10, 2014 |
| DOI | 10.2147/OTT.S60115 |
| Product codes mentioned | NJT |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1